Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Operating Margin 2011-2024 | ZTS

Current and historical operating margin for Zoetis (ZTS) over the last 10 years. The current operating profit margin for Zoetis as of December 31, 2024 is 29.09%.
  
Zoetis Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $9.26B $3.13B 33.85%
2024-09-30 $9.15B $3.05B 33.34%
2024-06-30 $8.92B $2.89B 32.46%
2024-03-31 $8.73B $2.99B 34.19%
2023-12-31 $8.54B $2.94B 34.36%
2023-09-30 $8.37B $2.88B 34.38%
2023-06-30 $8.22B $2.83B 34.40%
2023-03-31 $8.09B $2.63B 32.44%
2022-12-31 $8.08B $2.66B 32.87%
2022-09-30 $8.01B $2.57B 32.10%
2022-06-30 $8.00B $2.56B 32.05%
2022-03-31 $7.89B $2.53B 32.04%
2021-12-31 $7.78B $2.49B 32.00%
2021-09-30 $7.62B $2.40B 31.54%
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.65B 14.41%
2013-06-30 $4.40B $0.67B 15.32%
2013-03-31 $4.38B $0.74B 16.88%
2012-12-31 $4.34B $0.72B 16.56%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $69.350B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $93.202B 34.96
Takeda Pharmaceutical (TAK) Japan $48.619B 10.76
Daiichi Sankyo, - (DSNKY) Japan $47.708B 24.27
Sandoz Group AG (SDZNY) Switzerland $19.609B 0.00
Astellas Pharma (ALPMY) Japan $18.241B 10.72
Merck (MKKGY) Germany $17.913B 14.82
Summit Therapeutics (SMMT) United States $17.424B 0.00
Shionogi (SGIOY) Japan $14.411B 14.44
United Therapeutics (UTHR) United States $13.508B 12.23
Neurocrine Biosciences (NBIX) United States $10.610B 32.60
IPSEN (IPSEY) France $9.463B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.766B 59.06
Madrigal Pharmaceuticals (MDGL) United States $7.525B 0.00
Stevanato Group S.p.A (STVN) Italy $6.360B 40.38
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.739B 0.00
Soleno Therapeutics (SLNO) United States $3.757B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.119B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.961B 12.02
Hypermarcas (HYPMY) Brazil $2.534B 16.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.402B 14.90
Recursion Pharmaceuticals (RXRX) United States $2.299B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.037B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.827B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.766B 0.00
Indivior (INDV) United States $1.620B 6.87
Guardian Pharmacy Services (GRDN) United States $1.525B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.366B 174.00
Dyne Therapeutics (DYN) United States $1.332B 0.00
Ocular Therapeutix (OCUL) United States $1.306B 0.00
Ardelyx (ARDX) United States $1.299B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.915B 0.00
Harrow (HROW) United States $0.905B 0.00
Collegium Pharmaceutical (COLL) United States $0.887B 4.71
Avadel Pharmaceuticals (AVDL) Ireland $0.832B 0.00
AleAnna (ANNA) United States $0.790B 0.00
Xencor (XNCR) United States $0.753B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.650B 0.00
Bioventus (BVS) United States $0.619B 16.08
Organogenesis (ORGO) United States $0.619B 0.00
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Savara (SVRA) United States $0.563B 0.00
Relay Therapeutics (RLAY) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.526B 11.29
Verve Therapeutics (VERV) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.440B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.418B 0.00
Siga Technologies (SIGA) United States $0.412B 7.02
Zevra Therapeutics (ZVRA) United States $0.395B 0.00
Altimmune (ALT) United States $0.393B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 20.82
CytoDyn (CYDY) United States $0.316B 0.00
ProKidney (PROK) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Avita Medical (RCEL) United States $0.264B 0.00
OmniAb (OABI) United States $0.226B 0.00
Regulus Therapeutics (RGLS) United States $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.221B 26.02
Wellgistics Health (WGRX) United States $0.209B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Esperion Therapeutics (ESPR) United States $0.190B 24.00
Journey Medical (DERM) United States $0.174B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Korro Bio (KRRO) United States $0.157B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.156B 0.00
Larimar Therapeutics (LRMR) United States $0.153B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.152B 47.01
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Profound Medical (PROF) Canada $0.147B 0.00
Aclaris Therapeutics (ACRS) United States $0.144B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.119B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.104B 17.09
VAXART, INC (VXRT) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 8.29
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.08
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.16
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00